We are live on ! Find out more
IMVT icon

Immunovant
IMVT

40 hedge funds and large institutions have $194M invested in Immunovant in 2020 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

320% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 5

67% more funds holding

Funds holding: 24 → 40 (+16)

14% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 7

10% more capital invested

Capital invested by funds: $176M → $194M (+$17.3M)

2.64% more ownership

Funds ownership: 20.58% → 23.21% (+2.6%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
40
Holders Change
+16
Holders Change %
+66.67%
% of All Funds
0.88%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
21
Increased
8
Reduced
7
Closed
5
Calls
$412K
Puts
–
Net Calls
+$412K
Net Calls Change
+$412K

Top Buyers

Rank Fund Capital Flow
1
MP
Mangrove Partners
Connecticut
+$7.1M
2
Millennium Management
Millennium Management
New York
+$6.88M
3
IC
Ikarian Capital
Texas
+$5.09M
4
BlackRock
BlackRock
New York
+$4.56M
5
RSCM
Rock Springs Capital Management
Maryland
+$3.76M

Top Sellers

Rank Fund Capital Flow
1
AC
Athanor Capital
New York
-$7.93M
2
SCM
Sio Capital Management
New York
-$7.54M
3
GPCM
Granite Point Capital Management
Massachusetts
-$2.78M
4
PM
Prosight Management
Texas
-$1.55M
5
GTC
Ghost Tree Capital
New York
-$1.35M
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$314K +$288K +19,176 +1,918%
Geode Capital Management
27
Geode Capital Management
Massachusetts
$298K +$288K +19,175 New
SFM
28
Sphera Funds Management
Israel
$296K -$14.6K -968 -5%
Citadel Advisors
29
Citadel Advisors
Florida
$276K +$267K +17,756 New
QSS
30
Quantitative Systematic Strategies
Florida
$241K +$233K +15,509 New
Jane Street
31
Jane Street
New York
$186K +$180K +11,990 New
Marshall Wace
32
Marshall Wace
United Kingdom
$172K +$166K +11,036 New
Bank of America
33
Bank of America
North Carolina
$131K +$127K +8,412 New
S
34
SignatureFD
Georgia
$54K +$52.7K +3,500 New
Macquarie Group
35
Macquarie Group
Australia
$50K +$48.3K +3,208 New
JP Morgan Chase
36
JP Morgan Chase
New York
$45K +$43.7K +2,908 New
UBS Group
37
UBS Group
Switzerland
$37K +$19.3K +1,281 +119%
Citigroup
38
Citigroup
New York
$25K +$24.5K +1,628 New
LC
39
Lindbrook Capital
California
$16K +$15K +1,000 New
CSS
40
Cubist Systematic Strategies
Connecticut
$5K +$5.1K +339 New
AC
41
Athanor Capital
New York
– -$7.93M -500,000 Closed
SSA
42
Schonfeld Strategic Advisors
New York
– -$1.35M -85,000 Closed
ECM
43
ExodusPoint Capital Management
New York
– -$346K -21,800 Closed
PC
44
PA Capital
Virginia
– -$220K -13,871 Closed
6CM
45
683 Capital Management
New York
– -$213K -13,400 Closed
1
2

IMVT Hedge Fund Activity: Q1 2020 in Review

40 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Immunovant (IMVT) for Q1 2020, worth a combined $194M — up 9.8% from $176M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new IMVT positions and 5 closed out — a net gain of 16 holders — while 8 added to existing stakes and 7 trimmed.

The largest buyer was Mangrove Partners, adding an estimated $7.1M. The largest seller was Athanor Capital, exiting entirely with an estimated $7.93M sold.

  • 40 institutional investors held Immunovant (IMVT) as of Q1 2020, up from 24 in Q4 2019.
  • Funds reported $194M of Immunovant stock for Q1 2020, up 9.8% quarter-over-quarter.
  • 21 funds opened new Immunovant positions in Q1 2020 and 5 closed out, a net change of +16 holders.
  • The largest Immunovant buyer in Q1 2020 was Mangrove Partners, an estimated $7.1M added.
  • The largest Immunovant seller in Q1 2020 was Athanor Capital, an estimated $7.93M sold.

Based on aggregated 13F filings for Q1 2020.